A new trial from Italy challenges a decades-old assumption that autologous stem cell transplant is more effective than radioimmunotherapy for consolidation after follicular lymphoma relapse.
"Nuclear medicine has been available in India for the last 50 years. Whereas, PRRT therapies got US FDA approval last year," says Dr Sameer Sonar, Fellow, Harvard Medical School, USA, Group Director – Nuclear Medicine, PET CT Theranostics,Ruby Hall Clinic Group Hospitals